The role of oxygen therapy as second-line treatment for patients with obstructive sleep apnoea who are intolerant of continuous positive airway pressure therapy, and characterising ventilatory loop gain as a predictor of the success of therapy.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1039023]

Researchers: Dr Garrick Don (Principal investigator)

Brief description Obstructive sleep apnoea (OSA) is an increasingly common condition in Australia. Continuous positive airway pressure (CPAP) therapy is the _gold-standard� in OSA treatment, but a majority of sufferers are unable to tolerate this for the period required to treat their condition. We will be conducting a large Australian multi-centre, randomised, placebo controlled trial to investigate the utility of nocturnal oxygen therapy alone, in those people with OSA who are unable to tolerate CPAP.

Funding Amount $AUD 87,198.64

Funding Scheme NHMRC Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship

Subjects

Identifiers

nhmrc : 1039023
PURL : https://purl.org/au-research/grants/nhmrc/1039023

The role of oxygen therapy as second-line treatment for patients with obstructive sleep apnoea who are intolerant of continuous positive airway pressure therapy, and characterising ventilatory loop gain as a predictor of the success of therapy. [ 2012 - 2014 ]

Research Grant

Quick Links

Explore

External Resources

Share

The role of oxygen therapy as second-line treatment for patients with obstructive sleep apnoea who are intolerant of continuous positive airway pressure therapy, and characterising ventilatory loop gain as a predictor of the success of therapy. [ 2012 - 2014 ]

Research Grant

Related Organisations

Related People